portal hypertension

portal hypertension
Name	Portal Hypertension
Field	Hepatology, Gastroenterology
Symptoms	Ascites, Esophageal varices, Hepatic encephalopathy
Complications	Variceal bleeding, Hepatorenal syndrome, Spontaneous bacterial peritonitis
Causes	Cirrhosis, Schistosomiasis, Budd-Chiari syndrome
Risks	Chronic hepatitis B, Chronic hepatitis C, Alcohol use disorder
Diagnosis	Ultrasound, Hepatic venous pressure gradient, Endoscopy
Treatment	Non-selective beta blocker, Transjugular intrahepatic portosystemic shunt, Liver transplantation

portal hypertension is a clinical syndrome defined by an abnormally increased pressure within the portal venous system. This condition is most frequently a consequence of increased resistance to blood flow through the liver, often due to cirrhosis. The elevated pressure leads to the development of collateral circulation and can result in life-threatening complications such as severe gastrointestinal bleeding from Esophageal varices.

Definition and pathophysiology

The condition is formally defined by a Hepatic venous pressure gradient measurement exceeding 5 mmHg, with clinically significant sequelae typically appearing above 10 mmHg. The primary mechanism involves increased vascular resistance within the liver, which can occur at pre-hepatic, intra-hepatic, or post-hepatic levels. This resistance triggers a hyperdynamic circulatory state characterized by increased cardiac output and decreased systemic vascular resistance, mediated by vasodilators like nitric oxide. The ensuing portal pressure elevation forces blood to bypass the liver through portosystemic collaterals, leading to the development of Esophageal varices and Gastric varices.

Causes and classification

Etiologies are classified based on the anatomical site of increased resistance. Pre-hepatic causes include Portal vein thrombosis and external compression from conditions like Pancreatic cancer. The most common intra-hepatic causes are cirrhosis from Chronic hepatitis C, Alcohol use disorder, and Nonalcoholic steatohepatitis, as well as non-cirrhotic causes like Schistosomiasis and Congenital hepatic fibrosis. Post-hepatic causes involve impediments to hepatic venous outflow, such as Budd-Chiari syndrome, Right heart failure, and Constrictive pericarditis. This classification guides diagnostic evaluation and therapeutic strategies.

Signs and symptoms

Clinical manifestations are often related to the underlying liver disease and the consequences of portosystemic shunting. Common findings include Ascites, detectable on physical exam or Ultrasound, and Splenomegaly which may lead to Thrombocytopenia. The development of portosystemic collaterals can present as Esophageal varices or Caput medusae around the umbilicus. Hepatic encephalopathy manifests as neuropsychiatric symptoms ranging from confusion to coma. A crucial, often late, sign is acute upper gastrointestinal hemorrhage from ruptured varices, a medical emergency.

Diagnosis

Diagnosis involves a combination of clinical assessment, imaging, and direct pressure measurement. Ultrasound with Doppler is a first-line tool to assess the Portal vein, detect Ascites, and evaluate for Splenomegaly. Computed tomography or Magnetic resonance imaging can further delineate vascular anatomy and collateral vessels. Upper endoscopy is essential for screening and grading Esophageal varices. The gold standard for confirmation is measurement of the Hepatic venous pressure gradient via catheterization of the Hepatic veins, typically performed in specialized centers like the Mayo Clinic.

Management and treatment

Management focuses on treating the underlying cause, preventing variceal bleeding, and controlling complications. Primary prophylaxis for variceal hemorrhage involves Non-selective beta blockers like Propranolol or Nadolol, or Endoscopic variceal ligation. Acute bleeding is managed with Vasopressin analogues, Somatostatin analogues, Antibiotic prophylaxis for Spontaneous bacterial peritonitis, and urgent Endoscopy. For refractory Ascites or recurrent bleeding, Transjugular intrahepatic portosystemic shunt placement or Balloon-occluded retrograde transvenous obliteration may be indicated. The definitive treatment for eligible patients with advanced cirrhosis is Liver transplantation.

Prognosis and complications

The prognosis is intrinsically linked to the severity of the underlying liver disease, often quantified by the Child-Pugh score or the Model for End-Stage Liver Disease. Major complications dictate morbidity and mortality. These include life-threatening Variceal bleeding, Hepatorenal syndrome, Hepatic encephalopathy, and Spontaneous bacterial peritonitis. The development of Hepatocellular carcinoma, particularly in the setting of Chronic hepatitis B, further worsens outcomes. Ongoing management requires a multidisciplinary approach involving specialists in Hepatology, Interventional radiology, and Transplant surgery.

Category:Digestive system disorders Category:Hepatology